1993
DOI: 10.1159/000211134
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of the Bioactivity of Mometasone Furoate 0.1% Fatty Cream, Betamethasone Dipropionate 0.05% Cream and Betamethasone Valerate 0.1% Cream in Humans

Abstract: The bioactivity of a novel topical glucocorticosteroid, mometasone furoate 0.1 % fatty cream was compared with betamethasone dipropionate 0.05% cream and betametasone valerate 0.1% cream. An ultraviolet light (UV-B)-induced inflammation assay in humans was used, and the combined effect of a single, open application of the corticosteroids was evaluated. Reduction of UV-B induced inflammation was monitored by laser Doppler blood flowmetry, clinical skin scoring and skin reflectance spectrophotometry. Skin scorin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
1

Year Published

1998
1998
2016
2016

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 10 publications
0
5
1
Order By: Relevance
“…The introduction of objective bioinstrumental assessments has increased the sensitivity of VCA. Previous works had also advocated the induction of hyperaemia prior to VCA to reveal a more intensive vasoconstriction [14][15][16]. The present findings are at variance with this concept because the blanching effect was best detected when the arm was in the upright position.…”
Section: Discussioncontrasting
confidence: 67%
See 2 more Smart Citations
“…The introduction of objective bioinstrumental assessments has increased the sensitivity of VCA. Previous works had also advocated the induction of hyperaemia prior to VCA to reveal a more intensive vasoconstriction [14][15][16]. The present findings are at variance with this concept because the blanching effect was best detected when the arm was in the upright position.…”
Section: Discussioncontrasting
confidence: 67%
“…A stronger blanching was then evidenced for corticosteroids only, the peak effect being late (at 6 h) for mometasone furoate and weaker and more delayed (at 24 h) for betamethasone valerate as confirmed by the calculation of the area under the curve. It was not a real surprise as mometasone furoate is a potent corticosteroid [9,15,31,32]. In fact, the peak effect described here does not correspond to a maximum blanching that could occur a couple of hours before or after the predetermined assessment times.…”
Section: Discussionmentioning
confidence: 70%
See 1 more Smart Citation
“…44 These properties might contribute to the in vivo protective effect of the JW-E against UV light-induced skin inflammation; in fact, lipid peroxidation products exert acute inflammatory effects in mammalian skin, 45 and several papers support the usefulness of the UVB erythema test for evaluation of steroidal and non-steroidal antiinflammatory agents. 46,47 In conclusion, the present in vitro and in vivo findings demonstrate that the JW-E possesses a strong antioxidant/free radical-scavenging effectiveness, which is very likely due to the phenolic compounds contained in it. Furthermore, this extract gives excellent photoprotection against UVB-induced skin damage; thus its use could have important therapeutic applications in certain skin diseases caused, initiated or exacerbated by ROS and free radical overproduction.…”
Section: Resultsmentioning
confidence: 60%
“…Therefore, DCE appears disappointing from the therapeutical point of view, but scientifically speaking, DCE might respresent an 'opposite PC', with remarkable activities in fibroblasts and negligible influences on keratinocytes. This, however, does not apply to halogenated monoesters in general, as mometasone 17-furoate [22][23][24] is reported to be well tolerated. This drug, however, has been tested less extensively as compared to PC.…”
Section: Discussionmentioning
confidence: 99%